AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « any »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
anxiety < any < aorta  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000042 (2020) Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000081 (2020) Francisco Vílchez-Oya [Espagne] ; Julia María Sánchez-Schmidt [Espagne] ; Anna Agustí [Espagne] ; Ana Pros [Espagne]The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.
000122 (2020) Timothy M. Smith ; Anuj Tharakan ; Rebecca K. MartinTargeting ADAM10 in Cancer and Autoimmunity
000205 (2020) Karin Luttropp [Suède] ; Johan Dalén [Suède] ; Axel Svedbom [Suède] ; Mary Dozier [États-Unis] ; Christopher M. Black [États-Unis] ; Amy Puenpatom [États-Unis]Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review
000282 (2020) Panyang Xu [République populaire de Chine] ; Qi Zhou [République populaire de Chine] ; Jiancheng Xu [République populaire de Chine]Mechanism of thrombocytopenia in COVID-19 patients
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000376 (2020) Theodore A. Henderson [États-Unis] ; Muriel J. Van Lierop [États-Unis, Canada] ; Mary Mclean [États-Unis, Canada] ; John Michael Uszler [États-Unis] ; John F. Thornton [États-Unis, Canada] ; Yin-Hui Siow [États-Unis, Canada] ; Dan G. Pavel [États-Unis] ; Joe Cardaci [États-Unis, Australie] ; Phil Cohen [États-Unis, Canada]Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know
000448 (2020) Martina Bonacini [Italie] ; Alessandra Soriano [Italie] ; Luca Cimino [Italie] ; Luca De Simone [Italie] ; Elena Bolletta [Italie] ; Fabrizio Gozzi [Italie] ; Francesco Muratore [Italie] ; Maria Nicastro [Italie] ; Lucia Belloni [Italie] ; Alessandro Zerbini [Italie] ; Luigi Fontana [Italie] ; Carlo Salvarani [Italie] ; Stefania Croci [Italie]Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases
000453 (2020) Cristina Scavone [Italie] ; Simona Brusco [Italie] ; Michele Bertini [Italie] ; Liberata Sportiello [Italie] ; Concetta Rafaniello [Italie] ; Alice Zoccoli [Italie] ; Liberato Berrino [Italie] ; Giorgio Racagni [Italie] ; Francesco Rossi [Italie] ; Annalisa Capuano [Italie]Current pharmacological treatments for COVID-19: what's next?
000469 (2020) Jehun Song [Corée du Sud] ; Seongmin Kang [Corée du Sud] ; Seung Won Choi [Corée du Sud] ; Kwang Won Seo [Corée du Sud] ; Sunggun Lee [Corée du Sud] ; Min Wook So [Corée du Sud] ; Doo-Ho Lim [Corée du Sud]Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
000483 (2020) Antonio Vitale [Italie] ; Giulio Cavalli [Italie] ; Piero Ruscitti [Italie] ; Jurgen Sota [Italie] ; Serena Colafrancesco [Italie] ; Roberta Priori [Italie] ; Guido Valesini [Italie] ; Lorenza Maria Argolini [Italie] ; Elena Baldissera [Italie] ; Elena Bartoloni [Italie] ; Daniele Cammelli [Italie] ; Giovanni Canestrari [Italie] ; Elena Cavallaro [Italie] ; Maria Grazia Massaro [Italie] ; Paola Cipriani [Italie] ; Ginevra De Marchi [Italie] ; Salvatore De Vita [Italie] ; Giacomo Emmi [Italie] ; Micol Frassi [Italie] ; Roberto Gerli [Italie] ; Elisa Gremese [Italie] ; Florenzo Iannone [Italie] ; Marco Fornaro [Italie] ; Anna Paladini [Italie] ; Giuseppe Lopalco [Italie] ; Raffaele Manna [Italie] ; Alessandro Mathieu [Italie] ; Carlomaurizio Montecucco [Italie] ; Marta Mosca [Italie] ; Ilaria Piazza [Italie] ; Matteo Piga [Italie] ; Irene Pontikaki [Italie] ; Micol Romano [Italie] ; Silvia Rossi [Italie] ; Maurizio Rossini [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Rosaria Talarico [Italie] ; Bruno Frediani [Italie] ; Angela Tincani [Italie] ; Ombretta Viapiana [Italie] ; Gianfranco Vitiello [Italie] ; Paola Galozzi [Italie] ; Paolo Sfriso [Italie] ; Carla Gaggiano [Italie] ; Salvatore Grosso [Italie] ; Donato Rigante [Italie] ; Lorenzo Dagna [Italie] ; Roberto Giacomelli [Italie] ; Luca Cantarini [Italie]Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes
000547 (2020) Jhuma Sankar ; Nitin Dhochak ; S. K. Kabra ; Rakesh LodhaCOVID-19 in Children: Clinical Approach and Management
000573 (2020) Izabela Szczygielska ; El Bieta Hernik ; Agnieszka Gazda ; Beata Kołodziejczyk ; Piotr GietkaAssessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
000576 (2020) Fabrizio Dal Moro [Italie] ; Ugolino Livi [Italie]Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
000598 (2020) Angelo Fassio [Italie] ; Giovanni Adami [Italie] ; Alessandro Giollo [Italie] ; Ombretta Viapiana [Italie] ; Nazzarena Malavolta [Italie] ; Gianantonio Saviola [Italie] ; Roberto Bortolotti [Italie] ; Luca Idolazzi [Italie] ; Francesco Bertoldo [Italie] ; Maurizio Rossini [Italie] ; Davide Gatti [Italie]Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study.
000605 (2020) Byounghoon Brian Hwang [États-Unis] ; Laurie Engel [États-Unis] ; Said A. Goueli [États-Unis] ; Hicham Zegzouti [États-Unis]A homogeneous bioluminescent immunoassay to probe cellular signaling pathway regulation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "any" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "any" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    any
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021